Indemnity & Compensation Guidelines Indemnity & Compensation Guidelines PolicyAccess to Medicines Working Group (AMWG) Clinical TrialsClinical Trial Research Agreements Indemnity & Compensation Guidelines Research & Development Task Force (R&DTF) Tele-Trials Oncology Industry TaskforceAddressing the challenges of access to new cancer medications About the OIT Reports and resources Pharma Australia Inclusion Group (PAIG) Policy Submissions Strategic Agreement 2022-2027 Regenerative Medicines Consortium Programme Form of Indemnity – Standard Form of Indemnity – HREC Review only Compensation Guidelines
